Literature DB >> 19204229

Inadvertent evisceration of eyes containing uveal melanoma.

Ralph C Eagle1, Hans E Grossniklaus, Nasreen Syed, R Nick Hogan, William C Lloyd, Robert Folberg.   

Abstract

OBJECTIVES: To report an important complication of ocular evisceration therapy for blind, painful eyes that has been unreported in the literature, and to stress the need for careful preoperative evaluation to exclude occult neoplasms prior to therapy.
DESIGN: Multicenter, retrospective, nonrandomized clinicopathological case series of patients found to have previously unsuspected uveal malignant melanoma during histopathological examination of blind, painful eyes treated by evisceration.
RESULTS: Histopathological examination of evisceration specimens disclosed previously unsuspected uveal melanoma in 7 patients who were treated for blind, painful eyes. Inflammation caused by necrosis of the tumor and other ocular tissues led to misdiagnosis as endophthalmitis, orbital cellulitis, or idiopathic orbital inflammation in several cases. Preoperative imaging was not performed in 3 cases and failed to detect tumors in the remaining 4 cases. Failure of necrotic tumors to enhance contributed to misdiagnosis.
CONCLUSIONS: The presence of a malignant intraocular neoplasm should be excluded prior to evisceration of any blind eye or blind, painful eye, particularly with opaque media. Necrosis-related inflammation can confound the clinical diagnosis of occult lesions, as can failure of necrotic tumors to enhance on imaging studies.

Entities:  

Mesh:

Year:  2009        PMID: 19204229      PMCID: PMC2989176          DOI: 10.1001/archophthalmol.2008.543

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

1.  Review of 1028 bulbar eviscerations and enucleations. Changes in aetiology and frequency over a 20-year period.

Authors:  A B Hansen; C Petersen; S Heegaard; J U Prause
Journal:  Acta Ophthalmol Scand       Date:  1999-06

Review 2.  Enucleation, evisceration, and sympathetic ophthalmia.

Authors:  J R Bilyk
Journal:  Curr Opin Ophthalmol       Date:  2000-10       Impact factor: 3.761

3.  Unsuspected intraocular malignant melanomas.

Authors:  T A MAKLEY; R W TEED
Journal:  AMA Arch Ophthalmol       Date:  1958-09

4.  Sympathetic Ophthalmia after Evisceration.

Authors:  A D Ruedemann
Journal:  Trans Am Ophthalmol Soc       Date:  1963

5.  The 1998 Wendell Hughes Lecture. Evisceration: is sympathetic ophthalmia a concern in the new millennium?

Authors:  M R Levine; C R Pou; R H Lash
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1999-01       Impact factor: 1.746

6.  Sympathetic uveitis following evisceration.

Authors:  W R Green; A E Maumenee; T E Sanders; M E Smith
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1972 May-Jun

7.  Melanoma of the orbit: an interesting case following evisceration.

Authors:  R Macdonald; W C Edwards
Journal:  Surv Ophthalmol       Date:  1967-06       Impact factor: 6.048

8.  Necrotic choroidal melanoma with orbital inflammation.

Authors:  A Tabassian; J J Zuravleff
Journal:  Arch Ophthalmol       Date:  1995-12

9.  Intraocular malignant melanomas presenting with orbital inflammation.

Authors:  G E Rose; H B Hoh; R A Harrad; J L Hungerford
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

10.  [Six cases of sympathetic ophthalmia developing after evisceration].

Authors:  H Ikui; K Ueno
Journal:  Nihon Ganka Kiyo       Date:  1965-08
View more
  14 in total

1.  Uveal Melanoma Mimicking Advanced Coats' Disease in a Young Patient.

Authors:  Naina Gupta; William Terrell; Lynn Schoenfield; Claudia Kirsch; Colleen M Cebulla
Journal:  Ocul Oncol Pathol       Date:  2015-11-20

Review 2.  Necrotic Uveal Melanoma Mimics Orbital Cellulitis: A Review.

Authors:  Ahmad Abdel-Aty; Wendy L Linderman; Ninani Kombo; John Sinard; Renelle Pointdujour-Lim
Journal:  Ocul Oncol Pathol       Date:  2021-11-23

Review 3.  Uveal melanoma: From diagnosis to treatment and the science in between.

Authors:  Chandrani Chattopadhyay; Dae Won Kim; Dan S Gombos; Junna Oba; Yong Qin; Michelle D Williams; Bita Esmaeli; Elizabeth A Grimm; Jennifer A Wargo; Scott E Woodman; Sapna P Patel
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860

4.  Aggressive Ciliary Body Adenocarcinoma with Bilateral Lung Metastases: Histological, Molecular, Genetic and Clinical Aspects.

Authors:  Konstantinos Kopsidas; Hardeep Mudhar; Karen Sisley; David W Hammond; L Worthington; Kim Suvarna; Bernadette Foran; Sachin Salvi
Journal:  Ocul Oncol Pathol       Date:  2018-05-07

5.  Bioinformatics analyses of retinoblastoma reveal the retinoblastoma progression subtypes.

Authors:  Manjing Cao; Sha Wang; Jing Zou; Wanpeng Wang
Journal:  PeerJ       Date:  2020-05-21       Impact factor: 2.984

6.  Indications for destructive eye surgeries at the Yaounde Gynaeco-Obstetric and Paediatric Hospital.

Authors:  André Omgbwa Eballé; Viola Andin Dohvoma; Godefroy Koki; Abdouramani Oumarou; Assumpta Lucienne Bella; Côme Ebana Mvogo
Journal:  Clin Ophthalmol       Date:  2011-05-05

7.  Evisceration in the modern age.

Authors:  Laura T Phan; Thomas N Hwang; Timothy J McCulley
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

8.  Why Are B-Scans in Some Blind Eyes with Large Intraocular Masses Misinterpreted?

Authors:  Curtis E Margo
Journal:  Ocul Oncol Pathol       Date:  2021-03-23

9.  Retinoinvasive Uveal Melanoma: Report of 2 Cases and Review of the Literature.

Authors:  John P Gorham; Eszter Szalai; Jill R Wells; Hans E Grossniklaus
Journal:  Ocul Oncol Pathol       Date:  2017-04-14

10.  A 12-year retrospective survey of management of patients with malignant neoplasms in the orbital cavity in a brazilian cancer hospital.

Authors:  Daniela Sirianni; Cláudio Rodrigues Leles; Elismauro Francisco Mendonça
Journal:  Open Dent J       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.